logo
logo

Rare Cyte, Inc. announced it raised $24 Million in an initial filing from an offering of $24 Million

Sep 10, 2021about 4 years ago

Amount Raised

$24 Million

SeattleOther

Company Information

Company

RareCyte, Inc.

Location

2601 4th Avenue

Seattle, Washington, United States

About

Leaders across Research, Translational Medicine and the Clinic rely on RareCyte as a one-stop resource for Spatial Biology and Liquid Biopsy solutions. Headquartered in Seattle, WA, RareCyte is an innovative precision biology company that has developed technologies and end-to-end integrated platforms enabling advances in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy. Our highly multiplexed fluorescent imaging systems, reagents and contract services empower investigators to unlock spatial context for key biomarkers and develop therapeutics and companion diagnostics though rare cell analysis.

Related People

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech